(VIANEWS) – Activision Blizzard (ATVI), Omnicell (OMCL), Heico Corporation (HEI) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Activision Blizzard (ATVI)
39.3% sales growth and 8.21% return on equity
Activision Blizzard, Inc., together with its subsidiaries, develops and publishes interactive entertainment content and services in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through three segments: Activision, Blizzard, and King. It develops and distributes content and services on video game consoles, personal computers, and mobile devices, including subscription, full-game, and in-game sales, as well as by licensing software to third-party or related-party companies that distribute Activision and Blizzard products. The company also maintains a proprietary online gaming service, Battle.net that facilitates digital distribution of content, online social connectivity, and the creation of user-generated content. In addition, it operates esports leagues and offer digital advertising content; and provides warehousing, logistics, and sales distribution services to third-party publishers of interactive entertainment software, as well as manufacturers of interactive entertainment hardware products. The company's key product franchises include Call of Duty, World of Warcraft, Diablo, Hearthstone, Overwatch, Overwatch League, and Candy Crush. It serves retailers and distributors, including mass-market retailers, consumer electronics stores, discount warehouses, and game specialty stores through third-party distribution and licensing arrangements. The company is headquartered in Santa Monica, California.
Earnings Per Share
As for profitability, Activision Blizzard has a trailing twelve months EPS of $2.82.
PE Ratio
Activision Blizzard has a trailing twelve months price to earnings ratio of 27.34. Meaning, the purchaser of the share is investing $27.34 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.21%.
Volume
Today’s last reported volume for Activision Blizzard is 726514 which is 89.35% below its average volume of 6821790.
Moving Average
Activision Blizzard’s value is higher than its 50-day moving average of $76.00 and above its 200-day moving average of $76.42.
Previous days news about Activision Blizzard(ATVI)
- According to VentureBeat on Tuesday, 21 February, "The signed deal means Microsoft is living up to its promise to the Federal Trade Commission that it will make Call of Duty available to other platform companies like Nintendo if its $68.7 billion deal to acquire Activision Blizzard is approved."
- According to VentureBeat on Tuesday, 21 February, "If Microsoft’s planned acquisition of Activision Blizzard goes through, Battle.net will eventually be included in the GeForce Now integration.", "This new deal also signals support for the pending acquisition of Activision Blizzard by Microsoft. "
2. Omnicell (OMCL)
22.7% sales growth and 5.65% return on equity
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Earnings Per Share
As for profitability, Omnicell has a trailing twelve months EPS of $0.79.
PE Ratio
Omnicell has a trailing twelve months price to earnings ratio of 74.12. Meaning, the purchaser of the share is investing $74.12 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.65%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 12% and positive 31.5% for the next.
3. Heico Corporation (HEI)
20.8% sales growth and 14.14% return on equity
HEICO Corporation, through its subsidiaries, designs, manufactures, and sells aerospace, defense, and electronic related products and services. The company's Flight Support Group segment provides jet engine and aircraft component replacement parts; thermal insulation blankets and parts; renewable/reusable insulation systems; and specialty components. This segment also distributes hydraulic, pneumatic, structural, interconnect, mechanical, and electro-mechanical components for the commercial, regional, and general aviation markets; and offers repair and overhaul services for jet engine and aircraft component parts, avionics, instruments, composites, and flight surfaces of commercial aircraft, as well as for avionics and navigation systems, subcomponents, and other instruments utilized on military aircraft. Its Electronic Technologies Group segment provides electro-optical infrared simulation and test equipment; electro-optical laser products; electro-optical, microwave, and other power equipment; electromagnetic and radio frequency (RF) interference shielding and suppression filters; power conversion and interface products; interconnection devices; power electronics; and underwater locator beacons and emergency locator transmission beacons. This segment also offers traveling wave tube amplifiers and microwave power modules; memory products and specialty semiconductors; harsh environment connectivity products and custom molded cable assemblies; RF and microwave products; communications and electronic intercept receivers and tuners; self-sealing auxiliary fuel systems; active antenna systems and airborne antennas; nuclear radiation detectors; silicone products; power amplifiers; ceramic-to-metal feedthroughs and connectors; technical surveillance countermeasures equipment; RF receivers and sources; embedded computing solutions; test sockets and adapters; and radiation assurance services. The company was founded in 1957 and is headquartered in Hollywood, Florida.
Earnings Per Share
As for profitability, Heico Corporation has a trailing twelve months EPS of $1.91.
PE Ratio
Heico Corporation has a trailing twelve months price to earnings ratio of 91.45. Meaning, the purchaser of the share is investing $91.45 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.14%.
Sales Growth
Heico Corporation’s sales growth is 19.4% for the current quarter and 20.8% for the next.
4. First Horizon National (FHN)
20.6% sales growth and 10.7% return on equity
First Horizon Corporation operates as the bank holding company for First Horizon Bank that provides various financial services. The company operates through three segments: Regional Banking, Specialty Banking, and Corporate. It offers general banking services for consumers, businesses, financial institutions, and governments. The company also underwrites bank-eligible securities and other fixed-income securities eligible for underwriting by financial subsidiaries; sells loans and derivatives; and offers advisory services. In addition, it offers various services, such as mortgage banking; title insurance and loan-closing; brokerage; correspondent banking; nationwide check clearing and remittance processing; trust, fiduciary, and agency; equipment finance; and investment and financial advisory services. Further, the company sells mutual fund and retail insurance products; and credit cards. It operates approximately 500 banking offices in 22 states under the First Horizon Bank brand; and 400 banking centers in 12 states under the FHN Financial brand in the United States. The company was formerly known as First Horizon National Corporation and changed its name to First Horizon Corporation in November 2020. First Horizon Corporation was founded in 1864 and is headquartered in Memphis, Tennessee.
Earnings Per Share
As for profitability, First Horizon National has a trailing twelve months EPS of $2.08.
PE Ratio
First Horizon National has a trailing twelve months price to earnings ratio of 11.94. Meaning, the purchaser of the share is investing $11.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.7%.
Yearly Top and Bottom Value
First Horizon National’s stock is valued at $24.85 at 10:22 EST, under its 52-week high of $24.92 and way higher than its 52-week low of $16.78.
